Sign In
Buy IBB
$167.50
+3.23 (+1.97%)
At Close: Jun 03, 2026
How Are Biotech ETFs Reacting to These Q4 Earnings Releases?
06:25pm, Thursday, 10'th Feb 2022
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
Is Biotech Sector (IBB) Looking for Major Price Move?
11:37am, Wednesday, 09'th Feb 2022
The past four trading days have held roughly the same price areas within the major indices. Specifically, the S&P 500 (SPY) and the Nasdaq 100 (QQQ) have similar tight price action.
Biotech ETFs Muddled Despite Amgen Strength
07:20pm, Tuesday, 08'th Feb 2022
Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will return value to investors through greater share b
Biotech is an opportunity right now, says Trivariate Research CEO
05:09pm, Monday, 07'th Feb 2022
Adam Parker, founder and CEO of Trivariate Research, joins 'Closing Bell' how to invest in the tech sector.
3 Growth ETFs to Consider Buying During This Correction
10:30am, Saturday, 29'th Jan 2022
They've taken a beating, but the industries they track are still growing.
Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead
09:00am, Monday, 17'th Jan 2022
2021 has been a real tough year for biotech investors, and the start of 2022 doesn't bring a sign of relief yet. Nonetheless, if history is of any guide, large trading volumes over the past month are
How Biotech ETF (IBB) Confirmed Reversal Pattern in Price and Momentum
11:47am, Wednesday, 12'th Jan 2022
For roughly three months the biotechnology ETF (IBB) has been trending lower. Though it's made multiple attempts to clear the 50-Day moving average (DMA), it has failed.
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:43am, Wednesday, 05'th Jan 2022
Smart Beta ETF report for IBB
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:40am, Friday, 31'st Dec 2021
Sector ETF report for IBB
Play 5 High-Beta ETF Areas for January & Be a Bottom Fisher
09:12am, Thursday, 30'th Dec 2021
J.P. Moggan strategists believe that these high-beta ETF areas could winning picks for January 2022.
Biotech M&A Could Finally Perk Up in 2022
02:52pm, Monday, 27'th Dec 2021
Broadly speaking, mergers and acquisitions in the healthcare sector were steady in 2021, but for many investors, there weren't enough aimed at smaller biotechnology companies. As is often the case, ma
ETF Battles: IBB Vs XBI
09:45am, Monday, 27'th Dec 2021
Which biotech ETF is the better choice?
Martin & Co. Inc. TN Purchases 2,725 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
05:02pm, Thursday, 23'rd Dec 2021 Dakota Financial News
Martin & Co. Inc. TN lifted its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 9.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,478 shares of the financial services providers stock after buying an additional 2,725 shares during []
Martin & Co. Inc. TN Buys 2,725 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
04:28pm, Thursday, 23'rd Dec 2021 Dakota Financial News
Martin & Co. Inc. TN grew its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 9.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,478 shares of the financial services providers stock after acquiring an additional 2,725 shares during the period. []
Josh Brown on biotech: I really don't think there will be any activity on drug prices next year
01:43pm, Thursday, 23'rd Dec 2021
The "Halftime" crew discuss whether investors should position themselves in biotech in 2022.
